News

AIFA updates the Transparency Lists

AIFA press release. February 15, 2023

In order to allow the Regions and autonomous Provinces to apply the provisions of art. 9, paragraph 5 of the Law of 8 August 2002, n. 178 the Italian Medicines Agency publishes, pursuant to the AIFA Directorial Determination n. 166 of 10 February 2021 published in the Official Gazette - General Series n. 39 and in compliance with the orders of the Council of State n. 583/2023, 596/2023 and 605/2023, theThe list of medicines and their reference prices updated on February 15, 2023 inclusive of the reduction envisaged pursuant to the AIFA determination of 3 July 2006, of the additional
reduction of the 5% pursuant to the AIFA determination of 27 September 2006, of the art. 9 paragraph 1, of the Law of 28 February 2008 n. 31 (Payback) and paragraph 9 of art. 11 of Legislative Decree 78/2010 converted with amendments by the Law of 30 July 2010, n. 122.

The lists are published in compliance with the criteria defined by the AIFA Directorial Decision n. 166/2021 and in compliance with the Sentences of the Council of State n. 5858/2022 and 5863/2022.

List by Active Principle

List by business name

Related news: The role of AIFA in the negotiation and regulation of the price of medicines

Shortage of antibiotics, producers of generics: new pricing policies and needs monitoring

 

Redazione Fedaiisf

Promote the cohesion and union of all members to allow a univocal and homogeneous vision of the professional problems inherent in the activity of pharmaceutical sales reps.

Articoli correlati

Back to top button
Fedaiisf Federazione delle Associazioni Italiane degli Informatori Scientifici del Farmaco e del Parafarmaco